Missense GNAS variants affecting residues R201 (namely p.R201C, p.R201S, and p.R201H), and G227 (p.G227R, p.G227L, and p.G227K) of GNAS have been described in endocrine tumors and other human neoplasms. Here, GNAS is linked to malignant endocrine neoplasm.